398 related articles for article (PubMed ID: 20298811)
1. Hepatitis B virus DNA level predicts hepatic decompensation in patients with acute exacerbation of chronic hepatitis B.
Jeng WJ; Sheen IS; Liaw YF
Clin Gastroenterol Hepatol; 2010 Jun; 8(6):541-5. PubMed ID: 20298811
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of spontaneous decline of HBV DNA in chronic hepatitis B patients in 12 weeks].
He H; Xu ZN; Cai DC; Nai N; Ling N; Zeng WQ; Shi XF; Zhao YR; Zhou Z; Zhang DZ
Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):271-4. PubMed ID: 19403025
[TBL] [Abstract][Full Text] [Related]
3. [Chronic hepatitis B virus (HBV) infection: usefulness of the combination of HBeAg and ALT determination to predict a high HBV-DNA level and therefore the necessity of referral to a specialist for possible antiviral treatment].
Veldhuijzen IK; Mostert MC; Niesters HG; Richardus JH; de Man RA
Ned Tijdschr Geneeskd; 2008 Jun; 152(25):1426-30. PubMed ID: 18624006
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B.
Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
Gastroenterology; 2009 Feb; 136(2):505-12. PubMed ID: 19101558
[TBL] [Abstract][Full Text] [Related]
5. [Quantitative detection of intrahepatic hepatitis B virus DNA in patients with chronic hepatitis B].
Lu H; Ma LX; Xu WS; Zhang HY; Yu LJ; Duan HY
Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):173-5. PubMed ID: 12681068
[TBL] [Abstract][Full Text] [Related]
6. Combination of baseline parameters and on-treatment hepatitis B virus DNA levels to start and continue patients with lamivudine therapy.
Yuen MF; Fung J; Seto WK; Wong DK; Yuen JC; Lai CL
Antivir Ther; 2009; 14(5):679-85. PubMed ID: 19704171
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B.
Wong VW; Wong GL; Tsang SW; Hui AY; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
Antivir Ther; 2008; 13(4):571-9. PubMed ID: 18672536
[TBL] [Abstract][Full Text] [Related]
8. [Serum ALT and HBV DNA levels in patients with HBeAg-negative chronic hepatitis B].
Kim KH; Na IH; Cha JM; Cho YK; Park SY; Kim HP; Song CS; Heo J; Cho M
Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):284-92. PubMed ID: 14695695
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between HBV DNA serum level and acute exacerbation of the disease in chronic hepatitis B patients].
Zhou X; Gao Z; Yao J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Dec; 13(4):335-9. PubMed ID: 12759971
[TBL] [Abstract][Full Text] [Related]
10. Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Yang HI; Sherman M; Su J; Chen PJ; Liaw YF; Iloeje UH; Chen CJ
J Clin Oncol; 2010 May; 28(14):2437-44. PubMed ID: 20368541
[TBL] [Abstract][Full Text] [Related]
11. Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase.
Chu CM; Chen YC; Tai DI; Liaw YF
Clin Gastroenterol Hepatol; 2010 Jun; 8(6):535-40. PubMed ID: 20304099
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous increases in alanine aminotransferase levels in asymptomatic chronic hepatitis B virus-infected patients.
Kumar M; Chauhan R; Gupta N; Hissar S; Sakhuja P; Sarin SK
Gastroenterology; 2009 Apr; 136(4):1272-80. PubMed ID: 19208347
[TBL] [Abstract][Full Text] [Related]
13. Characterization of viral kinetics in patients with hepatitis B e antigen-positive chronic hepatitis B.
Wu IC; Chow NH; Cheng PN; Liu WC; Young KC; Chang WL; Chen CY; Tseng KC; Chang TT
J Med Virol; 2007 Jun; 79(6):663-9. PubMed ID: 17457902
[TBL] [Abstract][Full Text] [Related]
14. Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B.
Gish RG; Chang TT; Lai CL; de Man R; Gadano A; Poordad F; Yang J; Brett-Smith H; Tamez R
J Viral Hepat; 2010 Jan; 17(1):16-22. PubMed ID: 19622117
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of HBV DNA load in patients with chronic hepatitis B infection.
Madan K; Batra Y; Jha JK; Kumar S; Kalra N; Paul SB; Singh R; Duttagupta S; Panda SK; Acharya SK
Trop Gastroenterol; 2008; 29(2):84-90. PubMed ID: 18972767
[TBL] [Abstract][Full Text] [Related]
16. An extended two-year trial of lamivudine in Chinese patients with chronic hepatitis B.
Yao G; Cui Z; Wang B; Yao J; Zeng M
Chin Med J (Engl); 2002 Dec; 115(12):1814-8. PubMed ID: 12622930
[TBL] [Abstract][Full Text] [Related]
17. Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha.
van der Eijk AA; Niesters HG; Hansen BE; Heijtink RA; Janssen HL; Schalm SW; de Man RA
J Viral Hepat; 2006 Feb; 13(2):96-103. PubMed ID: 16436127
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of 'lamivudine pulse' therapy in HBeAg-positive patients with normal ALT*.
Sarin SK; Sandhu BS; Sharma BC; Jain M; Singh J; Malhotra V
J Viral Hepat; 2004 Nov; 11(6):552-8. PubMed ID: 15500556
[TBL] [Abstract][Full Text] [Related]
19. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection.
Chu CJ; Hussain M; Lok AS
Hepatology; 2002 Dec; 36(6):1408-15. PubMed ID: 12447866
[TBL] [Abstract][Full Text] [Related]
20. Discriminant value of serum HBV DNA levels as predictors of liver fibrosis in chronic hepatitis B.
Sanai FM; Helmy A; Bzeizi KI; Babatin MA; Al-Qahtani A; Al-Ashgar HA; Al-Mdani AS; Al-Akwaa A; Almutharea S; Khan MQ; Alghamdi AS; Farah T; Al-Hamoudi W; Saadeh M; Abdo AA
J Viral Hepat; 2011 Jul; 18(7):e217-25. PubMed ID: 21692936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
